Chou R, Qaseem A, Snow V, Casey D, Cross JT, Shekelle P, Owens DK (October 2007). "Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society". Ann. Intern. Med. 147 (7). ss. 478-91. doi:10.7326/0003-4819-147-7-200710020-00006. PMID17909209.
Beebe FA, Barkin RL, Barkin S (2005). "A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions". Am J Ther. 12 (2). ss. 151-71. doi:10.1097/01.mjt.0000134786.50087.d8. PMID15767833.
Bras H, Jankowska E, Noga B, Skoog B (1990). "Comparison of Effects of Various Types of NA and 5-HT Agonists on Transmission from Group II Muscle Afferents in the Cat". Eur. J. Neurosci. 2 (12). ss. 1029-1039. doi:10.1111/j.1460-9568.1990.tb00015.x. PMID12106064.
Jankowska E, Hammar I, Chojnicka B, Hedén CH (February 2000). "Effects of monoamines on interneurons in four spinal reflex pathways from group I and/or group II muscle afferents". Eur. J. Neurosci. 12 (2). ss. 701-14. doi:10.1046/j.1460-9568.2000.00955.x. PMID10712650.
Tüzün F, Unalan H, Oner N, Ozgüzel H, Kirazli Y, Içağasioğlu A, Kuran B, Tüzün S, Başar G (September 2003). "Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain". Joint, Bone, Spine. 70 (5). ss. 356-61. doi:10.1016/S1297-319X(03)00075-7. PMID14563464.
Ketenci A, Ozcan E, Karamursel S (July 2005). "Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain". International Journal of Clinical Practice. 59 (7). ss. 764-70. doi:10.1111/j.1742-1241.2004.00454.x. PMID15963201.
Carta M, Murru L, Botta P, Talani G, Sechi G, De Riu P, Sanna E, Biggio G (September 2006). "The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous system". Neuropharmacology. 51 (4). ss. 805-15. doi:10.1016/j.neuropharm.2006.05.023. PMID16806306.
Mascia MP, Bachis E, Obili N, Maciocco E, Cocco GA, Sechi GP, Biggio G (March 2007). "Thiocolchicoside inhibits the activity of various subtypes of recombinant GABA(A) receptors expressed in Xenopus laevis oocytes". European Journal of Pharmacology. 558 (1–3). ss. 37-42. doi:10.1016/j.ejphar.2006.11.076. PMID17234181.
Giavina-Bianchi P, Giavina-Bianchi M, Tanno LK, Ensina LF, Motta AA, Kalil J (June 2009). "Epileptic seizure after treatment with thiocolchicoside". Therapeutics and Clinical Risk Management. 5 (3). ss. 635-7. doi:10.2147/tcrm.s4823. PMC2731019 $2. PMID19707540.
Sechi G, De Riu P, Mameli O, Deiana GA, Cocco GA, Rosati G (October 2003). "Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat". Seizure. 12 (7). ss. 508-15. doi:10.1016/S1059-1311(03)00053-0. PMID12967581.
dx.doi.org
Thomas Mencke, Mathias Echternach, Stefan Kleinschmidt, Philip Lux, Volker Barth, Peter K. Plinkert, Thomas Fuchs-Buder: Laryngeal Morbidity and Quality of Tracheal Intubation. In: Anesthesiology. 98, 2003, S. 1049–1056, DOI:10.1097/00000542-200305000-00005.
See S, Ginzburg R (2008). "Choosing a skeletal muscle relaxant". Am Fam Physician. 78 (3). ss. 365-370. ISSN0002-838X. PMID18711953.
Chou R, Qaseem A, Snow V, Casey D, Cross JT, Shekelle P, Owens DK (October 2007). "Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society". Ann. Intern. Med. 147 (7). ss. 478-91. doi:10.7326/0003-4819-147-7-200710020-00006. PMID17909209.
Beebe FA, Barkin RL, Barkin S (2005). "A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions". Am J Ther. 12 (2). ss. 151-71. doi:10.1097/01.mjt.0000134786.50087.d8. PMID15767833.
Young, R.R., (Ed.) (1994). "Symposium: Role of tizanidine in the treatment of spasticity". Neurology. 44 (Suppl 9). ss. S1-80. PMID7970005.
Bras H, Jankowska E, Noga B, Skoog B (1990). "Comparison of Effects of Various Types of NA and 5-HT Agonists on Transmission from Group II Muscle Afferents in the Cat". Eur. J. Neurosci. 2 (12). ss. 1029-1039. doi:10.1111/j.1460-9568.1990.tb00015.x. PMID12106064.
Jankowska E, Hammar I, Chojnicka B, Hedén CH (February 2000). "Effects of monoamines on interneurons in four spinal reflex pathways from group I and/or group II muscle afferents". Eur. J. Neurosci. 12 (2). ss. 701-14. doi:10.1046/j.1460-9568.2000.00955.x. PMID10712650.
Young RR, Wiegner AW (June 1987). "Spasticity". Clin. Orthop. Relat. Res., 219. ss. 50-62. PMID3581584.
Tüzün F, Unalan H, Oner N, Ozgüzel H, Kirazli Y, Içağasioğlu A, Kuran B, Tüzün S, Başar G (September 2003). "Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain". Joint, Bone, Spine. 70 (5). ss. 356-61. doi:10.1016/S1297-319X(03)00075-7. PMID14563464.
Soonawalla DF, Joshi N (May 2008). "Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm". Journal of the Indian Medical Association. 106 (5). ss. 331-5. PMID18839644.
Ketenci A, Ozcan E, Karamursel S (July 2005). "Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain". International Journal of Clinical Practice. 59 (7). ss. 764-70. doi:10.1111/j.1742-1241.2004.00454.x. PMID15963201.
Carta M, Murru L, Botta P, Talani G, Sechi G, De Riu P, Sanna E, Biggio G (September 2006). "The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous system". Neuropharmacology. 51 (4). ss. 805-15. doi:10.1016/j.neuropharm.2006.05.023. PMID16806306.
Mascia MP, Bachis E, Obili N, Maciocco E, Cocco GA, Sechi GP, Biggio G (March 2007). "Thiocolchicoside inhibits the activity of various subtypes of recombinant GABA(A) receptors expressed in Xenopus laevis oocytes". European Journal of Pharmacology. 558 (1–3). ss. 37-42. doi:10.1016/j.ejphar.2006.11.076. PMID17234181.
Giavina-Bianchi P, Giavina-Bianchi M, Tanno LK, Ensina LF, Motta AA, Kalil J (June 2009). "Epileptic seizure after treatment with thiocolchicoside". Therapeutics and Clinical Risk Management. 5 (3). ss. 635-7. doi:10.2147/tcrm.s4823. PMC2731019 $2. PMID19707540.
Sechi G, De Riu P, Mameli O, Deiana GA, Cocco GA, Rosati G (October 2003). "Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat". Seizure. 12 (7). ss. 508-15. doi:10.1016/S1059-1311(03)00053-0. PMID12967581.
"M03CA01 Dantrolene". ATC/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology. 16 Ocak 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ocak 2024.
"M03CA01 Dantrolene". ATC/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology. 16 Ocak 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ocak 2024.
worldcat.org
See S, Ginzburg R (2008). "Choosing a skeletal muscle relaxant". Am Fam Physician. 78 (3). ss. 365-370. ISSN0002-838X. PMID18711953.